Delaware
(State
or Other Jurisdiction
of
Incorporation)
|
000-30929
(Commission
File Number)
|
13-4087132
(IRS
Employer Identification No.)
|
£
|
Written
communications pursuant to Rule 425 under the Securities
Act.
|
£
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act.
|
£
|
Pre-commencement
communications pursuant to Rule 14d-2b under the Exchange
Act.
|
£
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act.
|
Keryx
Biopharmaceuticals, Inc.
|
||||
(Registrant)
|
||||
Date:
October 24, 2007
|
||||
By:
|
/s/
Beth F. Levine
|
|||
Beth
F. Levine
|
||||
Chief
Compliance Officer, General Counsel
and
Secretary
|
Exhibit
|
||
Number
|
Description
|
|
99.1
|
Press
Release dated October 24, 2007.
|